David Miles
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 72
- HER2/EGFR in Cancer Research 48
- Cancer Treatment and Pharmacology 22
- Cancer Immunotherapy and Biomarkers 9
-
- Advanced Breast Cancer Therapies 14
- Co-authors
- Luca Gianni (7 shared papers)Véronique Dièras (10 shared papers)José Baselga (6 shared papers)Manfred Welslau (5 shared papers)Ian E. Krop (6 shared papers)Mark D. Pegram (7 shared papers)Ellie Guardino (9 shared papers)Sunil Verma (6 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Annals of Oncology (10 papers)Cancer Research (7 papers)British Journal of Cancer (4 papers)The Oncologist (3 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
David Miles
91 papers receiving 8.3k citations
David Miles's Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 5.2k
- Radiology, Nuclear Medicine and Imaging 2.1k
- Cancer Research 966
- Pulmonary and Respiratory Medicine 1.8k
- Immunology 924
Countries citing papers authored by David Miles
This map shows the geographic impact of David Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Miles more than expected).
Fields of papers citing papers by David Miles
This network shows the impact of papers produced by David Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Miles. The network helps show where David Miles may publish in the future.
Co-authors
The 25 scholars most cited alongside David Miles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer Hit paper breakdown → | 2012 | 2724 |
| 2 | Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Hit paper breakdown → | 2010 | 703 |
| 3 | Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial Hit paper breakdown → | 2017 | 477 |
| 4 | 2010 | 455 | |
| 5 | 1999 | 402 | |
| 6 | 2014 | 290 | |
| 7 | 1998 | 244 | |
| 8 | 2011 | 210 | |
| 9 | 1970 | 204 | |
| 10 | 2010 | 193 | |
| 11 | 2014 | 178 | |
| 12 | 1999 | 171 | |
| 13 | 2002 | 128 | |
| 14 | 2006 | 112 | |
| 15 | 2010 | 111 | |
| 16 | 2013 | 108 | |
| 17 | 1994 | 107 | |
| 18 | 2016 | 93 | |
| 19 | 2013 | 91 | |
| 20 | 2016 | 87 |
About David Miles
David Miles is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 94 papers that have together received 8.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (48 papers), Cancer Treatment and Pharmacology (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Breast Cancer Treatment Studies (14 papers), Advanced Breast Cancer Therapies (14 papers), Cancer Immunotherapy and Biomarkers (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Oncology (5.2k citations), Radiology, Nuclear Medicine and Imaging (2.1k citations), Cancer Research (966 citations), Pulmonary and Respiratory Medicine (1.8k citations) and Immunology (924 citations). David Miles has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Luca Gianni, Véronique Dièras, José Baselga, Manfred Welslau, Ian E. Krop, Mark D. Pegram, Ellie Guardino, Sunil Verma, Kim T. Blackwell and Fang Ting Liang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, British Journal of Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.